Xeris Biopharma Holdings, Inc.
XERS
Revenue
48.07M
▲7.43M▲18.28%
3 Months ChangeAssets
331.73M
▼-4.88M▼-1.45%
3 Months ChangeLiabilities
351.02M
▲5.23M▲1.51%
3 Months ChangeFree Cash Flow
-96.62M
▼-15.69M▼-19.38%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-08
Form 10-Q
ID: 0001867096-24-000162
2024-08-08
Form 8-K
ID: 0001867096-24-000157
2024-08-02
Form 8-K
ID: 0001867096-24-000137
2024-07-08
Form 8-K
ID: 0001867096-24-000124
2024-06-05
Form 8-K
ID: 0001867096-24-000102
2024-05-09
Form 10-Q
ID: 0001867096-24-000065
2024-05-09
Form 8-K
ID: 0001867096-24-000062
2024-03-06
Form 8-K
ID: 0001867096-24-000024
2024-01-04
Form 8-K
ID: 0001867096-24-000003
2023-11-09
Form 10-Q
ID: 0001867096-23-000139